載入中
NASDAQHealthcareMedical - Healthcare Information Services
最新資料
US$7.41
+US$0.11 · +1.51%
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
前收盤價
US$7.41
+US$0.11 · +1.51%
盤前
US$7.8469
+US$0.4369 · +5.90%
10月12日 上午7:11 ET
盤中時間採用ET。市場資料可能有所延遲。
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
日內區間
目前US$7.41
52週區間
目前US$7.41
盤中時間採用ET。市場資料可能有所延遲。
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
日內區間
目前US$7.41
52週區間
目前US$7.41
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 7727.1萬 USD | 6517.3萬 USD | 6237.1萬 USD | 4756萬 USD | 4045萬 USD |
| 銷貨成本 | 2945.7萬 USD | 2123.6萬 USD | 1945.8萬 USD | 1630.6萬 USD | 1522.9萬 USD |
| 毛利 | 4781.4萬 USD | 4393.7萬 USD | 4291.3萬 USD | 3125.4萬 USD | 2522.1萬 USD |
| 研究與開發 | 3356.7萬 USD | 3436.6萬 USD | 3696.9萬 USD | 3537.1萬 USD | 2657.8萬 USD |
| 銷售、一般及管理費用 | 8517.2萬 USD | 7632.2萬 USD | 8172.4萬 USD | 8408.3萬 USD | 7024萬 USD |
| 營業費用 | 1.19億 USD | 1.11億 USD | 1.18億 USD | 1.19億 USD | 9671萬 USD |
| 利息收入 | 187.2萬 USD | 336.2萬 USD | 454.7萬 USD | 132.4萬 USD | 2萬 USD |
| 利息支出 | 455.4萬 USD | 191.3萬 USD | 58.8萬 USD | 63.9萬 USD | 65.8萬 USD |
| 折舊和攤銷 | 952.9萬 USD | 859.6萬 USD | 833.6萬 USD | 557.1萬 USD | 360.9萬 USD |
| 營業利益 | −7092.5萬 USD | −6656.8萬 USD | −7482.6萬 USD | −8782.3萬 USD | −7148.9萬 USD |
| 淨利 | −7899.9萬 USD | −6249.3萬 USD | −7898.1萬 USD | −8744.9萬 USD | −7367.5萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
